Gender and Wealth Gaps Widen Type 2 Diabetes Crisis in China Tags α-Glucosidase inhibitors SGLT-2 Inhibitor Read more about Gender and Wealth Gaps Widen Type 2 Diabetes Crisis in China
GLP-1 Drugs Raise Recurrent Pancreatitis Risk in High-Risk Diabetes Patients Read more about GLP-1 Drugs Raise Recurrent Pancreatitis Risk in High-Risk Diabetes Patients
Reversal from Prediabetes to Normoglycemia Reduce Risk of Progression to Diabetes Read more about Reversal from Prediabetes to Normoglycemia Reduce Risk of Progression to Diabetes
SGLT2 Inhibitors Edge Out GLP-1s for Diabetic Foot Risks Tags Diabetic Neuropathy Diabetic foot. SGLT-2 Inhibitor Read more about SGLT2 Inhibitors Edge Out GLP-1s for Diabetic Foot Risks
SGLT2 Drugs Boost Hemoglobin Even with Ongoing Inflammation Tags SGLT-2 Inhibitor Read more about SGLT2 Drugs Boost Hemoglobin Even with Ongoing Inflammation
Semaglutide 2.4mg Delivers Weight Loss Without Muscle Sacrifice: SEMALEAN Study Read more about Semaglutide 2.4mg Delivers Weight Loss Without Muscle Sacrifice: SEMALEAN Study
SGLT2i + GLP-1RA Combo May Halve MACE Risk: Largest Real-World Analysis Tags SGLT-2 Inhibitor Read more about SGLT2i + GLP-1RA Combo May Halve MACE Risk: Largest Real-World Analysis
Meta-Analysis Delivers Clinical Breakthrough for GLP-1 RAs Effect to Reverse Prediabetes Read more about Meta-Analysis Delivers Clinical Breakthrough for GLP-1 RAs Effect to Reverse Prediabetes
Lower Tumor Incidence Observed With SGLT2 Inhibitors in T2DM Tags SGLT-2 Inhibitor Read more about Lower Tumor Incidence Observed With SGLT2 Inhibitors in T2DM
Enavogliflozin Add-On to Insulin Lowers HbA1c Without Added Safety Risk in T2DM Tags SGLT-2 Inhibitor Read more about Enavogliflozin Add-On to Insulin Lowers HbA1c Without Added Safety Risk in T2DM